368 related articles for article (PubMed ID: 16162026)
1. Handling missing data in patient-level cost-effectiveness analysis alongside randomised clinical trials.
Manca A; Palmer S
Appl Health Econ Health Policy; 2005; 4(2):65-75. PubMed ID: 16162026
[TBL] [Abstract][Full Text] [Related]
2. Missing data in trial-based cost-effectiveness analysis: An incomplete journey.
Leurent B; Gomes M; Carpenter JR
Health Econ; 2018 Jun; 27(6):1024-1040. PubMed ID: 29573044
[TBL] [Abstract][Full Text] [Related]
3. Is the whole larger than the sum of its parts? Impact of missing data imputation in economic evaluation conducted alongside randomized controlled trials.
Michalowsky B; Hoffmann W; Kennedy K; Xie F
Eur J Health Econ; 2020 Jul; 21(5):717-728. PubMed ID: 32108274
[TBL] [Abstract][Full Text] [Related]
4. When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts.
Jakobsen JC; Gluud C; Wetterslev J; Winkel P
BMC Med Res Methodol; 2017 Dec; 17(1):162. PubMed ID: 29207961
[TBL] [Abstract][Full Text] [Related]
5. Analyses of cost data in economic evaluations conducted alongside randomized controlled trials.
Doshi JA; Glick HA; Polsky D
Value Health; 2006; 9(5):334-40. PubMed ID: 16961551
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness in clinical trials: using multiple imputation to deal with incomplete cost data.
Burton A; Billingham LJ; Bryan S
Clin Trials; 2007; 4(2):154-61. PubMed ID: 17456514
[TBL] [Abstract][Full Text] [Related]
7. Are missing data adequately handled in cluster randomised trials? A systematic review and guidelines.
Díaz-Ordaz K; Kenward MG; Cohen A; Coleman CL; Eldridge S
Clin Trials; 2014 Oct; 11(5):590-600. PubMed ID: 24902924
[TBL] [Abstract][Full Text] [Related]
8. Multiple imputation methods for bivariate outcomes in cluster randomised trials.
DiazOrdaz K; Kenward MG; Gomes M; Grieve R
Stat Med; 2016 Sep; 35(20):3482-96. PubMed ID: 26990655
[TBL] [Abstract][Full Text] [Related]
9. How to deal with missing longitudinal data in cost of illness analysis in Alzheimer's disease-suggestions from the GERAS observational study.
Belger M; Haro JM; Reed C; Happich M; Kahle-Wrobleski K; Argimon JM; Bruno G; Dodel R; Jones RW; Vellas B; Wimo A
BMC Med Res Methodol; 2016 Jul; 16():83. PubMed ID: 27430559
[TBL] [Abstract][Full Text] [Related]
10. Multiple imputation strategies for zero-inflated cost data in economic evaluations: which method works best?
MacNeil Vroomen J; Eekhout I; Dijkgraaf MG; van Hout H; de Rooij SE; Heymans MW; Bosmans JE
Eur J Health Econ; 2016 Nov; 17(8):939-950. PubMed ID: 26497027
[TBL] [Abstract][Full Text] [Related]
11. Multiple imputation methods for handling missing data in cost-effectiveness analyses that use data from hierarchical studies: an application to cluster randomized trials.
Gomes M; Díaz-Ordaz K; Grieve R; Kenward MG
Med Decis Making; 2013 Nov; 33(8):1051-63. PubMed ID: 23913915
[TBL] [Abstract][Full Text] [Related]
12. Reference-based multiple imputation for missing data sensitivity analyses in trial-based cost-effectiveness analysis.
Leurent B; Gomes M; Cro S; Wiles N; Carpenter JR
Health Econ; 2020 Feb; 29(2):171-184. PubMed ID: 31845455
[TBL] [Abstract][Full Text] [Related]
13. The impact of using different imputation methods for missing quality of life scores on the estimation of the cost-effectiveness of lung-volume-reduction surgery.
Blough DK; Ramsey S; Sullivan SD; Yusen R;
Health Econ; 2009 Jan; 18(1):91-101. PubMed ID: 18435426
[TBL] [Abstract][Full Text] [Related]
14. Econometric Issues in Prospective Economic Evaluations Alongside Clinical Trials: Combining the Nonparametric Bootstrap With Methods That Address Missing Data.
Jalali A; Tamimi RM; McPherson SM; Murphy SM
Epidemiol Rev; 2022 Dec; 44(1):67-77. PubMed ID: 36104860
[TBL] [Abstract][Full Text] [Related]
15. Is using multiple imputation better than complete case analysis for estimating a prevalence (risk) difference in randomized controlled trials when binary outcome observations are missing?
Mukaka M; White SA; Terlouw DJ; Mwapasa V; Kalilani-Phiri L; Faragher EB
Trials; 2016 Jul; 17():341. PubMed ID: 27450066
[TBL] [Abstract][Full Text] [Related]
16. Handling Missing Data in Health Economics and Outcomes Research (HEOR): A Systematic Review and Practical Recommendations.
Mukherjee K; Gunsoy NB; Kristy RM; Cappelleri JC; Roydhouse J; Stephenson JJ; Vanness DJ; Ramachandran S; Onwudiwe NC; Pentakota SR; Karcher H; Di Tanna GL
Pharmacoeconomics; 2023 Dec; 41(12):1589-1601. PubMed ID: 37490207
[TBL] [Abstract][Full Text] [Related]
17. Multiple imputation for patient reported outcome measures in randomised controlled trials: advantages and disadvantages of imputing at the item, subscale or composite score level.
Rombach I; Gray AM; Jenkinson C; Murray DW; Rivero-Arias O
BMC Med Res Methodol; 2018 Aug; 18(1):87. PubMed ID: 30153796
[TBL] [Abstract][Full Text] [Related]
18. Combining multiple imputation and bootstrap in the analysis of cost-effectiveness trial data.
Brand J; van Buuren S; le Cessie S; van den Hout W
Stat Med; 2019 Jan; 38(2):210-220. PubMed ID: 30207407
[TBL] [Abstract][Full Text] [Related]
19. Missing... presumed at random: cost-analysis of incomplete data.
Briggs A; Clark T; Wolstenholme J; Clarke P
Health Econ; 2003 May; 12(5):377-92. PubMed ID: 12720255
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report.
Ramsey SD; Willke RJ; Glick H; Reed SD; Augustovski F; Jonsson B; Briggs A; Sullivan SD
Value Health; 2015 Mar; 18(2):161-72. PubMed ID: 25773551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
